Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid bindingPäll, Taavi; Gad, A.; Kasak, L.; Drews, Monika; Strömblad, Sraffan; Kogerman, PriitOncogene2004 / 47, p. 7874-7881 https://www.nature.com/articles/1208083